Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mateus Crespo

Showing results (51-60 of 60) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 60 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 9, 2025
NXP800 Activates the Unfolded Protein Response, Altering AR and E2F Function to Impact Castration-Resistant Prostate Cancer GrowthJonathan Welti, Denisa Bogdan, Ines Figueiredo, et al.
Molecular Cancer Therapeutics|February 27, 2024
Thio-2 Inhibits Key Signaling Pathways Required for the Development and Progression of Castration-resistant Prostate CancerAntje Neeb, Ines Figueiredo, Denisa Bogdan, et al.
Cancer Research|November 10, 2021
HER3 Is an Actionable Target in Advanced Prostate CancerVeronica Gil, Susana Miranda, Ruth Riisnaes, et al.
Cancer Discovery|January 12, 2021
Targeting the p300/CBP Axis in Lethal Prostate CancerJonathan Welti, Adam Sharp, Nigel Brooks, et al.
European Urology Oncology|June 26, 2025
PERSEUS1: An Open-label, Investigator-initiated, Single arm, Phase 2 Trial Testing the Efficacy of Pembrolizumab in Patients with Metastatic Castration-resistant Prostate Cancer with Mismatch Repair Deficiency and Other Immune-sensitive Molecular SubtypesPasquale Rescigno, Maria Dolores Fenor de la Maza, Holly Tovey, et al.
The Journal of Clinical Investigation|September 17, 2024
BCL2 expression is enriched in advanced prostate cancer with features of lineage plasticityDaniel Westaby, Juan M Jiménez-Vacas, Ines Figueiredo, et al.
Nature|October 16, 2023
Targeting myeloid chemotaxis to reverse prostate cancer therapy resistanceChristina Guo, Adam Sharp, Bora Gurel, et al.
The Journal of Clinical Investigation|September 5, 2018
Immunogenomic analyses associate immunological alterations with mismatch repair defects in prostate cancerDaniel Nava Rodrigues, Pasquale Rescigno, David Liu, et al.
The Journal of Clinical Investigation|November 2, 2018
Immunogenomic analyses associate immunological alterations with mismatch repair defects in prostate cancerDaniel Nava Rodrigues, Pasquale Rescigno, David Liu, et al.
Nature Communications|October 8, 2025
Elucidating molecularly stratified single agent, and combination, therapeutic strategies targeting MCL1 for lethal prostate cancerJuan M Jiménez-Vacas, Daniel Westaby, Ines Figueiredo, et al.
Pageof 6

Showing results (51-60 of 60) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 60 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 9, 2025
NXP800 Activates the Unfolded Protein Response, Altering AR and E2F Function to Impact Castration-Resistant Prostate Cancer GrowthJonathan Welti, Denisa Bogdan, Ines Figueiredo, et al.
Molecular Cancer Therapeutics|February 27, 2024
Thio-2 Inhibits Key Signaling Pathways Required for the Development and Progression of Castration-resistant Prostate CancerAntje Neeb, Ines Figueiredo, Denisa Bogdan, et al.
Cancer Research|November 10, 2021
HER3 Is an Actionable Target in Advanced Prostate CancerVeronica Gil, Susana Miranda, Ruth Riisnaes, et al.
Cancer Discovery|January 12, 2021
Targeting the p300/CBP Axis in Lethal Prostate CancerJonathan Welti, Adam Sharp, Nigel Brooks, et al.
European Urology Oncology|June 26, 2025
PERSEUS1: An Open-label, Investigator-initiated, Single arm, Phase 2 Trial Testing the Efficacy of Pembrolizumab in Patients with Metastatic Castration-resistant Prostate Cancer with Mismatch Repair Deficiency and Other Immune-sensitive Molecular SubtypesPasquale Rescigno, Maria Dolores Fenor de la Maza, Holly Tovey, et al.
The Journal of Clinical Investigation|September 17, 2024
BCL2 expression is enriched in advanced prostate cancer with features of lineage plasticityDaniel Westaby, Juan M Jiménez-Vacas, Ines Figueiredo, et al.
Nature|October 16, 2023
Targeting myeloid chemotaxis to reverse prostate cancer therapy resistanceChristina Guo, Adam Sharp, Bora Gurel, et al.
The Journal of Clinical Investigation|September 5, 2018
Immunogenomic analyses associate immunological alterations with mismatch repair defects in prostate cancerDaniel Nava Rodrigues, Pasquale Rescigno, David Liu, et al.
The Journal of Clinical Investigation|November 2, 2018
Immunogenomic analyses associate immunological alterations with mismatch repair defects in prostate cancerDaniel Nava Rodrigues, Pasquale Rescigno, David Liu, et al.
Nature Communications|October 8, 2025
Elucidating molecularly stratified single agent, and combination, therapeutic strategies targeting MCL1 for lethal prostate cancerJuan M Jiménez-Vacas, Daniel Westaby, Ines Figueiredo, et al.
Pageof 6